A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of DWN12088 in Patients With Idiopathic Pulmonary Fibrosis
Lay Description
Category
- Lungs, Breathing and Bronchial
- IRB Number
- 20220305HU
- NCT Number
- ct.gov registration not required
- Open to Enrollment
- Yes
Eligibility
- Eligible Ages
- Eligible Genders
- Accepts Healthy Volunteers
Inclusion Criteria
Exclusion Criteria
Study Design
Arm Groups
Study Contact
Darcy Bair-Kelps
(210) 540-7100
bairkelps@uthscsa.edu
Monique Johnson
JohnsonM13@uthscsa.edu
Anoop Nambiar
(210) 617-5256
nambiar@uthscsa.edu
Hilda Pomroy
+1 (210) 450-9022
pomroy@uthscsa.edu
Darcy Bair-Kelps
(210) 540-7100
bairkelps@uthscsa.edu
Principal Investigator
Anoop Nambiar